What is Clinitech Laboratory Ltd. Quarterly Revenue?

Clinitech Laboratory Ltd. Quarterly Revenue Clinitech Laboratory Mar-2026 Quarterly Revenue is Rs 0 Cr which is growth of 0% YoY.

What is Clinitech Laboratory Ltd. Quarterly Net Profit?

Clinitech Laboratory Ltd. Quarterly Net Profit Clinitech Laboratory Mar-2026 Quarterly Net Profit is Rs 0 Cr which is growth of 0% YoY.

What is Clinitech Laboratory Ltd. Annual Revenue?

Clinitech Laboratory Ltd. Annual Revenue Clinitech Laboratory Mar-2026 Annual Revenue is Rs 10 Cr which is growth of 14.2% YoY.

What is Clinitech Laboratory Ltd. Annual Net Profit?

Clinitech Laboratory Ltd. Annual Net Profit Clinitech Laboratory Mar-2026 Annual Net Profit is Rs 0 Cr which is growth of 7.0% YoY.

What is Clinitech Laboratory Ltd. Total Shareholders Fund?

Clinitech Laboratory Ltd. Total Shareholders Fund Clinitech Laboratory Mar-2026 Total Shareholders Fund is Rs 9 Cr which is growth of 4.8% YoY.

What is Clinitech Laboratory Ltd. Total Assets?

Clinitech Laboratory Ltd. Total Assets Clinitech Laboratory Mar-2026 Total Assets is Rs 11 Cr which is growth of 1.9% YoY.

What is Clinitech Laboratory Ltd. Book Value Per Share?

Clinitech Laboratory Ltd. Book Value Per Share Clinitech Laboratory Mar-2026 Book Value Per Share is 41 Rs which is growth of 4.8% YoY.

What is Clinitech Laboratory Ltd. ROE?

Clinitech Laboratory Ltd. ROE Clinitech Laboratory Mar-2026 ROE is 5% which is growth of 0.1% YoY.

What is Clinitech Laboratory Ltd. Cash From Operating Activity?

Clinitech Laboratory Ltd. Cash From Operating Activity Clinitech Laboratory Mar-2026 Cash From Operating Activity is Rs -1 Cr which is growth of -1.9% YoY.

What is Clinitech Laboratory Ltd. Net Cash Flow?

Clinitech Laboratory Ltd. Net Cash Flow Clinitech Laboratory Mar-2026 Net Cash Flow is Rs -1 Cr which is growth of -142.6% YoY.

Clinitech Laboratory Ltd.

BSE: 544220

Download real time

-1.65(-4.90%)

32.13% Fall from 52W High

1,200

BSE Volume

BSE 07 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Clinitech Laboratory quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Clinitech Laboratory competitor comparison and performance snapshot within industry

Clinitech Laboratory annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Clinitech Laboratory Mar-2026 Annual Revenue is Rs 10 Cr which is growth of 14.2% YoY.
POSITIVE
Annual Net Profit Clinitech Laboratory Mar-2026 Annual Net Profit is Rs 0 Cr which is growth of 7.0% YoY.

Clinitech Laboratory Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
SR_A Total Rev. Ann. ⌄	14.9%	16.1%	9.7	8.5	6.4	6.4	6.5	4.6
TotalOperatingRevenues_A Operating Rev. Ann.	14.1%	15.6%	9.5	8.2	6.4	6.4	6.4	4.6
OI_A Other Income Ann.	-	-	0.2	0.2	0	0	0.1	0
OEXPNS_A Operating Exp. Ann.	19.3%	18.1%	8.5	7.4	5.4	5	5.3	3.7
OEXPNS_A Operating Exp. Ann.	19.3%	18.1%	8.5	7.4	5.4	5	5.3	3.7
OP_A Operating Profit Ann.	-10.6%	4.6%	1	0.8	1	1.4	1.1	0.8
OPMPCT_A OPM Ann. %	-21.4%	-10.5%	10.30%	9.83%	15.23%	21.23%	16.52%	17.93%
TotalExpenses_A Total Exp. Ann. ⌄	18.3%	17.3%	9.1	7.9	5.9	5.5	5.8	4.1
OtherExpenses_A Other Exp. Ann.	20.5%	16.6%	2.8	2.7	1.8	1.6	1.7	1.3
EmployeeBenefitExpenses_A Employee Exp. Ann.	15.7%	20.9%	3.1	2.9	2.3	2	1.8	1.2
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	-5%	5.9%	1.2	1.1	1	1.4	1.1	0.9
EBIDTPCT_A EBITDA Ann. margin %	-17.1%	-8.3%	12.25%	12.52%	15.79%	21.48%	17.64%	18.85%
INT_A Interest Ann.	0%	0%	0.1	0.1	0.1	0.1	0.1	0.1
DEP_A Depr.	0%	10.8%	0.5	0.5	0.4	0.5	0.4	0.3
PBT_A PBT Ann.	-12.6%	0%	0.6	0.6	0.5	0.9	0.7	0.6
TAX_A Tax Ann.	-12.6%	14.9%	0.2	0.2	0.1	0.3	0.2	0.1
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-12.6%	0%	0.4	0.4	0.4	0.6	0.5	0.4
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	-12.6%	0%	0.4	0.4	0.4	0.6	0.5	0.4
NETPCT_A NPM Ann. %	-22.7%	-12.8%	4.45%	4.79%	5.79%	9.65%	8.02%	8.83%
EPS_adj_A EPS Adj. latest Ann.	-11.1%	1.1%	1.9	1.7	1.6	2.7	2.3	1.8

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

14.1%

2Y CAGR

23.1%

3Y CAGR

14.9%

5Y CAGR

16.1%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

3Y CAGR

-12.6%

Net Profit Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

14.9%

2Y CAGR

25.5%

3Y CAGR

19.3%

5Y CAGR

18.1%

Operating Expenses Annual Cr growth is lower than historical averages.

Clinitech Laboratory balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Clinitech Laboratory Mar-2026 Total Shareholders Fund is Rs 9 Cr which is growth of 4.8% YoY.
POSITIVE
Total Assets Clinitech Laboratory Mar-2026 Total Assets is Rs 11 Cr which is growth of 1.9% YoY.

Clinitech Laboratory Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	57.1%	46%	9.3	8.8	3.6	2.4	1.9	1.4
EQCAP_A Equity Share Capital Ann.	15.3%	26.9%	2.3	2.3	1.7	1.5	1.5	0.7
TotalShareCapital_A Total Share Capital Ann.	15.3%	26.9%	2.3	2.3	1.7	1.5	1.5	0.7
ReservesAndSurplus_A Reserves Plus Surplus Ann.	98.1%	58.5%	7	6.6	1.9	0.9	0.4	0.7
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	98.1%	58.5%	7	6.6	1.9	0.9	0.4	0.7
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-31.9%	0%	0.6	0.2	0.4	1.9	0.5	0.6
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-				1.5
CL_A Total Current Liabilities Ann. ⌄	-15.1%	6.6%	1.1	1.7	1.6	1.8	1.4	0.8
TradePayables_A Trade Payables Ann.	0%	-4.4%	0.4	0.6	0.4	0.4	0.5	0.5
OtherCurrentLiabilities_A Other Current Liabilities Ann.	58.7%	32%	0.4	0.7	0.2	0.1	0.1	0.1
ShortTermProvisions_A ST Provisions Ann.	-30.7%	0%	0.2	0.4	0.5	0.6	0.3	0.2
TL_A Total Capital Plus Liabilities Ann.	22%	32.2%	10.9	10.7	5.6	6	3.7	2.7
FixedAssets_A Fixed Assets Ann. ⌄	19%	28.9%	3.2	3.1	2.7	1.9	2.1	0.9
TangibleAssets_A Tangible Assets Ann.	17.3%	21.3%	2.1	2.1	1.7	1.3	1.7	0.8
IntangibleAssets_A Intangible Assets Ann.	-	-	0		0	0
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	-				0.6	0.4	0.1
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	-4.2%	26.8%	3.6	3.4	2.9	4.1	2.3	1.1
NonCurrentInvestments_A Non Current Investments Ann.	-63.2%	0%	0.1	0.1	0.1	2	0.1	0.1
DeferredTaxAssets_A Deferred Tax Assets Ann.	0%	14.9%	0.2	0.2	0.2	0.2	0.1	0.1
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-	-	0.1
CA_A Total Current Assets Ann. ⌄	54.7%	35.8%	7.4	7.3	2.7	2	1.4	1.6
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	56%	25.9%	1.9	1.5	0.6	0.5	0.4	0.6
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	37.9%	47.6%	2.1	3.1	0.7	0.8	0.1	0.3
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	47.6%	0.7	0.8	0.2	0	0.1	0.1
OtherCurrentAssets_A Other Current Assets Ann.	58.7%	27.2%	2	1.4	0.9	0.5	0.7	0.6
TA_A Total Assets Ann.	22%	32.2%	10.9	10.7	5.6	6	3.7	2.7
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-63.2%	0%	0.1	0.1	0.1	2	0.1	0.1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

1.9%

2Y CAGR

39.5%

3Y CAGR

22%

5Y CAGR

32.2%

Total Assets Annual growth is lower than historical averages.

Total Current Liabilities Ann.

1Y CHG

-35.3%

2Y CAGR

-17.1%

3Y CAGR

-15.1%

5Y CAGR

6.6%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

5.7%

2Y CAGR

60.7%

3Y CAGR

57.1%

5Y CAGR

46%

Total ShareHolders Funds Annual growth is lower than historical averages.

Clinitech Laboratory ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Clinitech Laboratory Mar-2026 Book Value Per Share is 41 Rs which is growth of 4.8% YoY.
POSITIVE
ROE Clinitech Laboratory Mar-2026 ROE is 5% which is growth of 0.1% YoY.

Clinitech Laboratory Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
BVSH_A BVSH Ann.	36.6%	14.1%	40.5	38.7	21.1	15.9	12.3	20.9
ROA_A RoA Ann. %	-27.5%	-23.4%	3.87%	3.68%	6.61%	10.16%	13.90%	14.72%
ROE_A ROE Ann. %	-43.8%	-30.9%	4.56%	4.46%	10.46%	25.75%	27.73%	28.94%
ROCE_A ROCE Ann. %	-31.8%	-26.4%	6.82%	6.75%	14.52%	21.53%	32.60%	31.57%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-16.6%	-8.1%	12.48%	12.86%	15.87%	21.53%	17.84%	19.02%
PBITMargin_A EBIT Ann. Margin %	-21.2%	-12.2%	7.10%	7.40%	9.02%	14.51%	11.87%	13.63%
PBTMargin_A PBT Ann. Margin %	-22.3%	-11.9%	6.37%	6.73%	7.89%	13.60%	10.99%	11.98%
NETPCT_A NPM Ann. %	-22.7%	-12.8%	4.45%	4.79%	5.79%	9.65%	8.02%	8.83%
ASETTO_A Asset Turnover Ann. %	-11.5%	-	0.9	1	1.1	1.3	2	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	85.3%	27.2%	7	4.4	1.7	1.1	1	2.1
QuickRatio_A Quick Ratio Ann.	84.7%	25.8%	6.3	4.1	1.5	1	0.9	2
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	-	-	-	-	-	-
EarningRetention_A Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-	-	6.3	6.1
EVPerNetSales_A EV Per Net Sales Ann.	-	-	0.7	0.7	-	-	-	-
PBV_A Price To Book Value Adjusted	-30.1%	-12.4%	0.79	0.8	2.31	2.31	2.6	1.53
EVPerEBITDA_A EV Per EBITDA Ann.	-	-	5.3	5.8	-	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-	-	0.8	1.1	-	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-	-
EYield_A Earnings Yield Ann.	-	-	0.1	0
DEBT_CE_A Total Debt to Total Equity Ann.	-	-	0		0.2	0.4	0.5	0.4

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

2.2%

2Y CAGR

-34%

3Y CAGR

-43.8%

5Y CAGR

-30.9%

ROE Annual % is growing faster than historical averages.

RoA Ann. %

1Y CHG

5.2%

2Y CAGR

-23.5%

3Y CAGR

-27.5%

5Y CAGR

-23.4%

RoA Annual % is growing faster than historical averages.

Current Ratio Ann.

1Y CHG

59.1%

2Y CAGR

102.9%

3Y CAGR

85.3%

5Y CAGR

27.2%

Current Ratio Annual growth is stable compared to historical averages.

Clinitech Laboratory cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Clinitech Laboratory Mar-2026 Cash From Operating Activity is Rs -1 Cr which is growth of -1.9% YoY.
NEGATIVE
Net Cash Flow Clinitech Laboratory Mar-2026 Net Cash Flow is Rs -1 Cr which is growth of -142.6% YoY.

Clinitech Laboratory Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21
CFO_A Cash from Operating Act. Ann. ⌄	-	-	-0.9	-0.9	-1.4	1.3	1	0.4
PBT_A PBT Ann.	-12.6%	0%	0.6	0.6	0.5	0.9	0.7	0.6
INT_A Interest Ann.	0%	0%	0.1	0.1	0.1	0.1	0.1	0.1
TAX_A Tax Ann.	-12.6%	14.9%	0.2	0.2	0.1	0.3	0.2	0.1
CFI_A Cash from Investing Act. Ann.	-	-	-0.4	-0.7	0.8	-0.7	-1.5	0.5
CFA_A Cash from Financing Act. Ann.	44.2%	-	0.3	4	0.6	0.1	0.3	-0.9
NCF_A Net Cash Flow Ann. ⌄	-	-	-1	2.4	-0.1	0.7	-0.2	0
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	214.1%	59.5%	3.1	0.7	0.8	0.1	0.3	0.3
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	37.9%	47.6%	2.1	3.1	0.7	0.8	0.1	0.3

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Financing Act. Ann.

1Y CHG

-92.5%

2Y CAGR

-29.3%

3Y CAGR

44.2%

Cash from Financing Annual Activity is falling faster than historical averages.

Clinitech Laboratory investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

32.13% Fall from 52W High

Clinitech Laboratory quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Clinitech Laboratory - Competitors/Peers

Clinitech Laboratory competitor comparison and performance snapshot within industry

Clinitech Laboratory - Annual

Clinitech Laboratory annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Clinitech Laboratory Mar-2026 Annual Revenue is Rs 10 Cr which is growth of 14.2% YoY.

Annual Net Profit Clinitech Laboratory Mar-2026 Annual Net Profit is Rs 0 Cr which is growth of 7.0% YoY.

Clinitech Laboratory - Balance Sheet

Clinitech Laboratory balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Clinitech Laboratory Mar-2026 Total Shareholders Fund is Rs 9 Cr which is growth of 4.8% YoY.

Total Assets Clinitech Laboratory Mar-2026 Total Assets is Rs 11 Cr which is growth of 1.9% YoY.

Clinitech Laboratory - Ratios

Clinitech Laboratory ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Book Value Per Share Clinitech Laboratory Mar-2026 Book Value Per Share is 41 Rs which is growth of 4.8% YoY.

ROE Clinitech Laboratory Mar-2026 ROE is 5% which is growth of 0.1% YoY.

Clinitech Laboratory - Cash Flow

Clinitech Laboratory cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Cash From Operating Activity Clinitech Laboratory Mar-2026 Cash From Operating Activity is Rs -1 Cr which is growth of -1.9% YoY.

Net Cash Flow Clinitech Laboratory Mar-2026 Net Cash Flow is Rs -1 Cr which is growth of -142.6% YoY.

Clinitech Laboratory - Documents

Clinitech Laboratory investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access